Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion type Assertion NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_head.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion description "[In conclusion, all human ovarian cancers express immunologically-detectable levels of HER2, indicating that IHC measurement underestimates the true frequency of HER2-expressing ovarian cancers and may limit patient access to otherwise clinically meaningful HER2-targeted therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_provenance.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion evidence source_evidence_literature NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_provenance.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion SIO_000772 23189165 NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_provenance.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion wasDerivedFrom befree-2016 NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_provenance.
- NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_assertion wasGeneratedBy ECO_0000203 NP1031928.RAhg-_p53mMJvlJldqwWuw0Mt0Bzd56CyLsI5MSRcIomw130_provenance.